Published in:
01-02-2014 | Short Communication
Adipose tissue INSR splicing in humans associates with fasting insulin level and is regulated by weight loss
Published in: Diabetologia | Issue 2/2014
Login to get accessAbstract
Aims/hypothesis
The insulin receptor (INSR) has two protein isoforms based on alternative splicing of exon 11. INSR-A promotes cell growth whereas INSR-B predominantly regulates glucose homeostasis. In this study we investigated whether weight loss regulates INSR alternative splicing and the expression of splicing factors in adipose tissue.
Methods
To determine the relative ratio of the INSR splice variants, we implemented the PCR-capillary electrophoresis method with adipose tissue samples from two weight-loss-intervention studies, the Kuopio Obesity Surgery study (KOBS, n = 108) and a very low calorie diet (VLCD) intervention (n = 32), and from the population-based Metabolic Syndrome in Men study (METSIM, n = 49).
Results
Expression of INSR-B mRNA variant increased in response to weight loss induced by both bariatric surgery (p = 1 × 10−5) and the VLCD (p = 1 × 10−4). The adipose tissue expression of INSR-B correlated negatively with fasting insulin levels in the pooled data of the three studies (p = 3 × 10−22). Finally, expression of several splicing factors correlated negatively with the expression of the INSR-B variant. The strongest correlation was with HNRNPA1 (p = 1 × 10−5), a known regulator of INSR exon 11 splicing.
Conclusions/interpretation
INSR splicing is regulated by weight loss and associates with insulin levels. The effect of weight loss on INSR splicing could be mediated by changes in the expression of splicing factors.